EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Synchronous Ovarian Sertoli–Leydig Cell and Clear Cell Papillary Renal Cell Tumors: A Rare Case Without Mutations in Cancer-Associated Genes

Manuela Macera, Simone Morra iD, Mario Ascione iD, Daniela Terracciano iD, Monica Ianniello, Giovanni Savarese iD, Carlo Alviggi, Giuseppe Bifulco, Nicola Longo iD, Annamaria Colao iD, Paola Ungaro, Paolo Emidio Macchia iD

Current Oncology · 2025

DOI: 10.3390/curroncol32080429 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Current Oncology, 2025. Verfasst von Manuela Macera und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Medicina Clinica e Chirurgia, Scuola di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, 80131 Napoli, Italy. Hauptthemen laut MEDLINE: Sertoli-Leydig Cell Tumor, Ovarian Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Sertoli–Leydig cell tumors (SLCTs) are rare ovarian neoplasms that account for less than 0.5% of all ovarian tumors. They usually affect young women and often present with androgenic symptoms. We report a unique case of a 40-year-old woman diagnosed with both SLCT and clear cell papillary renal cell carcinoma (CCP-RCC), a rare tumor association with unclear pathogenesis. (2)

Methods

Both tumors were treated surgically. The diagnostic workup included hormonal testing, imaging studies, and extensive genetic testing, including DICER1 mutation analysis and multiplex ligation-dependent probe amplification (MLPA), as well as the examination of a next-generation sequencing (NGS) panel covering ~280 cancer-related genes. (3)

Results

Histopathologic examination confirmed a well-differentiated SLCT and CCP-RCC. No pathogenic variants in DICER1 were identified by WES or MLPA. No clinically relevant changes were found in the extended NGS panel either, so a known hereditary predisposition could be ruled out. The synchronous occurrence of both tumors without genomic alterations could indicate a sporadic event or as yet unidentified mechanisms. (4)

Conclusions

This case highlights the importance of a multidisciplinary approach in the management of rare tumor compounds. The exclusion of DICER1 mutations and the absence of genetic findings adds new evidence to the limited literature and underscores the importance of long-term surveillance and further research into potential shared oncogenic pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sertoli-Leydig Cell TumorOvarian NeoplasmsCarcinoma, Renal CellKidney NeoplasmsNeoplasms, Multiple PrimaryHumansFemaleAdultMutationRibonuclease III

Stichwörter der Autor:innen

Sertoli-Leydig cell tumor (SLCT)androgenic ovarian tumorcase reportclear cell papillary renal cell carcinoma (CCP-RCC)genetic predisposition

Substanzen

Ribonuclease III

Autor:innen und Institutionen

  • Dipartimento di Medicina Clinica e Chirurgia, Scuola di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, 80131 Napoli, Italy.
  • Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche, Scuola di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, 80131 Napoli, Italy.
  • Dipartimento di Sanità Pubblica, Scuola di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, 80131 Napoli, Italy.
  • Dipartimento di Scienze Mediche Traslazionali, Scuola di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, 80131 Napoli, Italy.
  • AMES, Centro Polidiagnostico Strumentale SRL, Casalnuovo di Napoli, 80013 Napoli, Italy.
  • Istituto degli Endotipi in Oncologia, Metabolismo e Immunologia "G. Salvatore" del CNR (IEOMI-CNR), 80131 Napoli, Italy.

ORCID-Profile: Simone Morra, Mario Ascione, Daniela Terracciano, Giovanni Savarese, Nicola Longo, Annamaria Colao, Paolo Emidio Macchia

Zitieren

APA

Macera, M., Morra, S., Ascione, M., Terracciano, D., Ianniello, M., Savarese, G., Alviggi, C., Bifulco, G., Longo, N., Colao, A., Ungaro, P., & Macchia, P. E. (2025). Synchronous Ovarian Sertoli–Leydig Cell and Clear Cell Papillary Renal Cell Tumors: A Rare Case Without Mutations in Cancer-Associated Genes. Current Oncology. https://doi.org/10.3390/curroncol32080429

Vancouver

Macera M, Morra S, Ascione M, Terracciano D, Ianniello M, Savarese G, et al. Synchronous Ovarian Sertoli–Leydig Cell and Clear Cell Papillary Renal Cell Tumors: A Rare Case Without Mutations in Cancer-Associated Genes. Current Oncology. 2025. doi:10.3390/curroncol32080429

BibTeX
@article{Macera2025,
  author = {Macera, Manuela and Morra, Simone and Ascione, Mario and Terracciano, Daniela and Ianniello, Monica and Savarese, Giovanni and Alviggi, Carlo and Bifulco, Giuseppe and Longo, Nicola and Colao, Annamaria and Ungaro, Paola and Macchia, Paolo Emidio},
  title = {Synchronous Ovarian Sertoli–Leydig Cell and Clear Cell Papillary Renal Cell Tumors: A Rare Case Without Mutations in Cancer-Associated Genes},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32080429}
}
Kostenlos starten →